If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
Maybe the svs situation is affecting or stifling the sp? I remember svs being being quite popular a few years back and I have a small amount of alba with them. Maybe there a quite few holders in the same boat with svs. I haven't used them for a year since i got sick of their constant cold sales calling.. Just a thought.
A lot of movement today. 480p to 440p, then back up to 465p? Looks like a tree shake to me?
It's funny how the FDA approved the female Viagra equivalent, even though it has reportedly serious side effects, but drags it's feet for nearly 18 months over Parsortix which could save millions of lives. On the sp, I wouldn't be surprised if we had another buying spike if the Fed decides against an interest rate rise in September.
The sp is recovering well after the dip yesterday. It's been 1 year, 4 months and 1 week since Parsortix FDA submission! It's an understatement to say AGL holders have been more than patient. Hopefully a happy Xmas 2015 for AGL holders?
Merkel has said there will be no new deal/bailout within the last hour. In five hours Greece will default (10pm GMT) and then there's the referendum on Sunday.. Hmm. I wondering if next week might be the time to buy? Just a thought and I'm probably completely wrong! GLA
Good to see this rise, especially when the sp was down in the 50s in January. My 79p average is looking a bit more sensible by the day. I agree with Drums,I think the reality of Parsortix is beginning to sink in now. When FDA finally arrives I think £1 will be considered cheap and take over speculation will probably kick off again.
Thanks for posting a very interesting watch there rafboy, a good presentation. Last week was certainly a good news week. So the Daily Mail picked up on this story (ovarian results) with no help from us at least? Angle being picked on the radar maybe now?
http://www.telegraph.co.uk/finance/personalfinance/investing/11512833/Neil-Woodford-Some-parts-of-biotech-are-in-a-bubble.html A pretty neutral objective assessment. He says British Biotech share prices are "on the floor", but the some US biotechs are demonstrating clear signs of a bubble. It does make me wonder though, if the ultimate future of Angle is a take over once FDA approval has arrived for Parsortix? If his sentiments are correct about the lack of interest/patience with British biotech? Any thoughts?